Edwards Lifesciences (EW) Gross Margin Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 212.00 |
| Dec 31, 2025 | 301.00 |
| Sep 30, 2025 | 240.00 |
| Jun 30, 2025 | 327.00 |
| Mar 31, 2025 | 214.00 |
| Dec 31, 2024 | 329.00 |
| Sep 30, 2024 | 732.00 |
| Jun 30, 2024 | 785.00 |
| Mar 31, 2024 | 177.00 |
| Dec 31, 2023 | 419.00 |
| Sep 30, 2023 | 465.00 |
| Jun 30, 2023 | 671.00 |
| Mar 31, 2023 | 736.00 |
| Dec 31, 2022 | 4,946.00 |
| Sep 30, 2022 | 672.00 |
| Jun 30, 2022 | 547.00 |
| Mar 31, 2022 | 209.00 |
| Dec 31, 2021 | 450.00 |
| Sep 30, 2021 | 345.00 |
| Jun 30, 2021 | 237.00 |
| Mar 31, 2021 | 174.00 |
| Dec 31, 2020 | 135.00 |
| Sep 30, 2020 | -80.00 |
| Jun 30, 2020 | -4.00 |
| Mar 31, 2020 | -45.00 |
| Dec 31, 2019 | 158.00 |
| Sep 30, 2019 | 95.00 |
| Jun 30, 2019 | -168.00 |
| Mar 31, 2019 | 459.00 |
| Dec 31, 2018 | 282.00 |
| Sep 30, 2018 | 106.00 |
| Jun 30, 2018 | -219.00 |
| Mar 31, 2018 | -175.00 |
| Dec 31, 2017 | -184.00 |
| Sep 30, 2017 | -103.00 |
| Jun 30, 2017 | 185.00 |
| Mar 31, 2017 | 332.00 |
| Dec 31, 2016 | 3.00 |
| Sep 30, 2016 | 320.00 |
| Jun 30, 2016 | 297.00 |
| Mar 31, 2016 | 302.00 |
| Dec 31, 2015 | 271.00 |
| Sep 30, 2015 | 362.00 |
| Jun 30, 2015 | 178.00 |
| Mar 31, 2015 | 592.00 |
| Dec 31, 2014 | 338.00 |
| Sep 30, 2014 | 257.00 |
| Jun 30, 2014 | 408.00 |